• Bifendate (DDB): Applied Protocols for Hepatoprotection and

  2026-08-05

  Bifendate (DDB) stands out as a robust hepatoprotection agent, combining multi-step autophagy inhibition with lipid metabolism regulation. This guide distills the latest experimental workflows and troubleshooting strategies, translating recent mechanistic insights into actionable protocols for bench researchers.

• BMS-345541: Precision IKK-1/IKK-2 Inhibition in Cell and Ang

  2026-08-04

  BMS-345541 (free base) offers unmatched specificity for IKK-1/IKK-2, enabling precise dissection of the NF-κB pathway in inflammation and angiogenesis models. This guide details robust experimental workflows, troubleshooting strategies, and leverages recent breakthroughs in vascular research to maximize assay success.

• Multilayered Control of TRIM46 Expression in Axon Formation

  2026-08-04

  This study uncovers how alternative splicing, nonsense-mediated decay, and protein stability jointly regulate the neuron-specific and temporally precise expression of TRIM46—a key axon determinant. The findings reveal a multilayered mechanism ensuring TRIM46 protein is induced at the right developmental stage, providing new insight into axon specification and neuronal polarity.

• Renal Blood Flow Effects of Norepinephrine in Septic Rats: C

  2026-08-03

  This study investigates how norepinephrine and phenylephrine, in combination with potassium channel blockers, affect renal blood flow in septic rats. It reveals that K+ channel blockade can exacerbate reductions in renal perfusion when vasoactive agents are administered, highlighting complex interactions in adrenergic signaling relevant for cardiovascular and sepsis research.

• GKT137831: Dual Nox1/Nox4 Inhibition for Redox and Membrane

  2026-08-03

  Explore GKT137831, a potent dual NADPH oxidase Nox1/Nox4 inhibitor, and its unique value in bridging redox biology with membrane integrity research. This article uncovers assay design insights and novel applications in oxidative stress and ferroptosis.

• Mdivi-1: Selective DRP1 Inhibitor for Mitochondrial Dynamics

  2026-08-02

  Mdivi-1 stands out as a selective DRP1 inhibitor that empowers researchers to dissect mitochondrial fission, apoptosis, and neuroprotection in both cell and animal models. This article bridges experimental insights from recent literature with hands-on workflows and troubleshooting tips, enabling robust, reproducible research using APExBIO's Mdivi-1.

• 0.4% Trypan Blue Solution: Technical Guide for Cell Viabilit

  2026-08-01

  0.4% Trypan Blue Solution is an established azo dye for cell staining, used to rapidly distinguish viable from non-viable cells in cell culture and cytotoxicity workflows. It is unsuitable for diagnostic or clinical applications and should be handled following validated research protocols to ensure data reliability.

• Thrombin B Chain Fragment: Strategic Insights for Translatio

  2026-07-31

  This thought-leadership article explores the mechanistic significance of thrombin as a trypsin-like serine protease in hemostasis, vascular biology, and beyond. Integrating recent protocol advances and competitive insights, we guide translational researchers on leveraging the Coagulation Factor II (Thrombin) B Chain Fragment [Homo sapiens] from APExBIO for high-fidelity modeling, assay optimization, and novel research applications. The discussion is elevated through evidence-based analysis and cross-referencing with both foundational and emergent literature.

• Sunitinib in Renal Cell Carcinoma: Ferroptosis-Driven Advanc

  2026-07-31

  Explore the evolving role of Sunitinib as a multi-targeted receptor tyrosine kinase inhibitor in renal cell carcinoma research, with a unique focus on ferroptosis and enhanced sensitivity strategies. Gain actionable insights for experimental design and a deeper understanding of apoptosis and cell cycle arrest mechanisms.

• AM 281 and the CB1-CREB Axis: New Frontiers in TBI Research

  2026-07-30

  Explore how AM 281, a potent CB1 cannabinoid receptor antagonist, is catalyzing new strategies in translational neuropharmacology. This thought-leadership article combines mechanistic insight into the CB1-CREB-GLT-1 pathway and practical recommendations for researchers tackling memory impairment and neuronal death in traumatic brain injury models.

• Bedaquiline: Diarylquinoline Antibiotic Workflows in TB & Ca

  2026-07-30

  Bedaquiline empowers researchers to tackle both multi-drug resistant tuberculosis and cancer metabolism with dual-targeted precision. This article provides actionable protocols, novel host-directed synergies, and troubleshooting guidance to maximize experimental outcomes using this advanced diarylquinoline antibiotic.

• XAV-939: Precision Modulation of Wnt/β-Catenin in Stem Cell

  2026-07-29

  Discover how XAV-939 (NVP-XAV939) enables high-specificity Wnt/β-catenin pathway modulation in stem cell, cancer, and fibrosis research. This article uniquely explores decision-making for practical assay design and translational impact, grounded in the latest scientific evidence.

• HEY2 Regulates Cardiac Mitochondrial Metabolism and Homeosta

  2026-07-29

  This study uncovers how the transcriptional repressor HEY2 modulates cardiac energy metabolism by repressing mitochondrial oxidative genes, impacting heart failure progression. Genome-wide and functional analyses reveal an evolutionarily conserved HEY2/HDAC1-Ppargc1/Cpt axis crucial for cardiac homeostasis, with implications for targeting metabolic dysregulation in heart disease.

• Nanomedicine Restores Stromal Homeostasis in Pancreatic Canc

  2026-07-28

  Fu et al. introduce a multistage, acid-responsive nanomedicine designed to sequentially remodel the fibrotic stroma in pancreatic ductal adenocarcinoma, enabling significantly improved gemcitabine delivery and tumor regression in vivo. This approach marks a critical shift from stromal ablation to homeostasis restoration, holding translational promise for overcoming chemoresistance in dense tumor microenvironments.

• Macrophage EV-miR-660 Drives Breast Cancer Metastasis via NF

  2026-07-28

  This study reveals how tumor-associated macrophage-derived extracellular vesicles deliver microRNA-660 to breast cancer cells, suppressing KLHL21 and activating NF-κB p65. These findings highlight a novel intercellular communication pathway promoting metastasis and suggest molecular targets for intervention in metastatic breast cancer.

16464 records 1/1098 page Next 12345 下5页 Last page